Replies to post #102203 on Biotech Values

[Regulardoc]

In the words of Mark Fuhrman, I would venture a guess, "never."

[DFRAI]

Dew Diligence - scripts info and revenue

Any inkling on scripts info , surprised nobody on this board has access

Have you made any progress on sales estimates or perhaps profit estimates for MNTA

I recall one analyst estimating gross profit of 1.70 per share for 2nd half of 2010 (excludes the reimbursement due Sandoz/Novartis) - it seems way too high in light of the recent price action for MNTA.